NCT05702489View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated Influenza

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

900

Participants

Timeline

Start Date

July 17, 2022

Primary Completion Date

May 26, 2023

Study Completion Date

October 13, 2023

Conditions
Influenza, Human
Interventions
DRUG

ZX-7101A

a drug to treatment influenza in Chinese adults

Trial Locations (1)

Unknown

Zhongshan Hospital Affiliated to Fudan University, Shanghai

Sponsors
All Listed Sponsors
lead

Nanjing Zenshine Pharmaceuticals

INDUSTRY